Neuroprotection in vascular dementia: A future path

Journal of the Neurological Sciences

Volumn 322, Issue 1-2, 2012, Pages 232-236

  Skoog, Ingmar ^a   Korczyn, Amos D ^b   Guekht, Alla ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b TEL AVIV UNIVERSITY   (Israel)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Pathology; Post stroke cognitive impairment; Therapy; Vascular cognitive impairment; Vascular dementia

Indexed keywords

ACTOVEGIN; CEREBROLYSIN; CITICOLINE; GALANTAMINE; MEMANTINE;

ALZHEIMER DISEASE; ARTICLE; DRUG MECHANISM; HUMAN; LIFESTYLE MODIFICATION; MONOTHERAPY; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; COGNITION DISORDERS; DEMENTIA, VASCULAR; FORECASTING; HEME; HUMANS; NEUROPROTECTIVE AGENTS; RISK FACTORS;

EID: 84867582424     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.02.013     Document Type: Article

References (45)

1. S. Sacuiu, D. Gustafson, M. Sjogren, X. Guo, S. Ostling, and B. Johansson Secular changes in cognitive predictors of dementia and mortality in 70-year-olds Neurology 75 9 Aug. 31 2010 779 785
2. D. Gustafson, E. Rothenberg, K. Blennow, B. Steen, and I. Skoog An 18-year follow-up of overweight and risk of Alzheimer disease Arch Intern Med 163 13 Jul. 14 2003 1524 1528
3. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-year longitudinal study of blood pressure and dementia Lancet 347 9009 Apr. 27 1996 1141 1145
4. S.L. Seliger, D.S. Siscovick, C.O. Stehman-Breen, D.L. Gillen, A. Fitzpatrick, and A. Bleyer Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study J Am Soc Nephrol 15 7 Jul. 2004 1904 1911
5. A.B. Newman, A.L. Fitzpatrick, O. Lopez, S. Jackson, C. Lyketsos, and W. Jagust Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort J Am Geriatr Soc 53 7 Jul. 2005 1101 1107
6. K. Mehlig, I. Skoog, X. Guo, M. Schutze, D. Gustafson, and M. Waern Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg Am J Epidemiol 167 6 Mar. 15 2008 684 691
7. T.A. Treves, and A.D. Korczyn Modeling the dementia epidemic CNS Neurosci Ther 18 2 Feb. 2012 175 178
8. United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects: The 2010 Revision 2011 2010
9. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, and C.J. Paciorek National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 9785 Jul. 2 2011 31 40
10. G. Danaei, M.M. Finucane, J.K. Lin, G.M. Singh, C.J. Paciorek, and M.J. Cowan National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants Lancet 377 9765 Feb. 12 2011 568 577
11. F. Farzadfar, M.M. Finucane, G. Danaei, P.M. Pelizzari, M.J. Cowan, and C.J. Paciorek National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants Lancet 377 9765 Feb. 12 2011 578 586
12. M.M. Finucane, G.A. Stevens, M.J. Cowan, G. Danaei, J.K. Lin, and C.J. Paciorek National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants Lancet 377 9765 Feb. 12 2011 557 567
13. X. Guo, M. Waern, K. Sjogren, L. Lissner, C. Bengtsson, and C. Bjorkelund Midlife respiratory function and incidence of Alzheimer's disease: a 29-year longitudinal study in women Neurobiol Aging 28 3 Mar. 2007 343 350
14. I. Skoog, P.J. Olesen, K. Blennow, B. Palmertz, S.C. Johnson, and E.D. Bigler Head size may modify the impact of white matter lesions on dementia Neurobiol Aging Mar. 17 2011 [Electronic publication ahead of print]
15. S. Wiederkehr, M. Simard, C. Fortin, and R. van Reekum Comparability of the clinical diagnostic criteria for vascular dementia: a critical review. Part I J Neuropsychiatry Clin Neurosci 20 2 2008 150 161
16. K.M. Hayden, P.P. Zandi, C.G. Lyketsos, A.S. Khachaturian, L.A. Bastian, and G. Charoonruk Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study Alzheimer Dis Assoc Disord 20 2 Apr. 2006 93 100
17. A.D. Korczyn, and V. Vakhapova Is vascular cognitive impairment a useful concept? J Neurol Sci 299 1-2 Dec. 15 2010 2 4
18. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 277 10 Mar. 12 1997 813 817
19. R. Barber, A. Gholkar, P. Scheltens, C. Ballard, I.G. McKeith, and J.T. O'Brien Medial temporal lobe atrophy on MRI in dementia with Lewy bodies Neurology 52 6 Apr. 12 1999 1153 1158
20. R. Barber, P. Scheltens, A. Gholkar, C. Ballard, I. McKeith, and P. Ince White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging J Neurol Neurosurg Psychiatry 67 1 Jul. 1999 66 72
21. J. Victoroff, W.J. Mack, S.A. Lyness, and H.C. Chui Multicenter clinicopathological correlation in dementia Am J Psychiatry 152 10 Oct. 1995 1476 1484
22. A.D. Korczyn Mixed dementia - the most common cause of dementia Ann N Y Acad Sci 977 Nov. 2002 129 134
23. A. Baskys, and A.C. Hou Vascular dementia: pharmacological treatment approaches and perspectives Clin Interv Aging 2 3 2007 327 335
24. S. Black, G.C. Roman, D.S. Geldmacher, S. Salloway, J. Hecker, and A. Burns Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial Stroke 34 10 Oct. 2003 2323 2330
25. D. Wilkinson, R. Doody, R. Helme, K. Taubman, J. Mintzer, and A. Kertesz Donepezil in vascular dementia: a randomized, placebo-controlled study Neurology 61 4 Aug. 26 2003 479 486
26. G.C. Roman, S. Salloway, S.E. Black, D.R. Royall, C. DeCarli, and M.W. Weiner Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size Stroke 41 6 Jun. 2010 1213 1221
27. T. Erkinjuntti, A. Kurz, S. Gauthier, R. Bullock, S. Lilienfeld, and C.V. Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 9314 Apr. 13 2002 1283 1290
28. A.P. Auchus, H.R. Brashear, S. Salloway, A.D. Korczyn, P.P. De Deyn, and C. Gassmann-Mayer Galantamine treatment of vascular dementia: a randomized trial Neurology 69 5 Jul. 31 2007 448 458
29. J.M. Orgogozo, A.S. Rigaud, A. Stoffler, H.J. Mobius, and F. Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 7 Jul. 2002 1834 1839
30. G. Wilcock, H.J. Mobius, and A. Stoffler A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) Int Clin Psychopharmacol 17 6 Nov. 2002 297 305
31. R.W. Jones Dimebon disappointment Alzheimers Res Ther 2 5 2010 25
32. H. Samadi, and D. Sultzer Solanezumab for Alzheimer's disease Expert Opin Biol Ther 11 6 Jun. 2011 787 798
33. G.A. Kerchner, and A.L. Boxer Bapineuzumab Expert Opin Biol Ther 10 7 Jul. 2010 1121 1130
34. P.N. Tariot, M.R. Farlow, G.T. Grossberg, S.M. Graham, S. McDonald, and I. Gergel Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial JAMA 291 3 Jan. 21 2004 317 324
35. A.B. Guekht, H. Moessler, P.H. Novak, and E.I. Gusev Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial J Stroke Cerebrovasc Dis 20 4 Jul. 2011 310 318
36. G. Ortega, C. Jacas, M. Quintana, M. Ribó, E. Santamarina, and O. Maisterra Citicoline treatment prevents neurocognitive decline after a first ischemic stroke Cerebrovasc Dis 29 Suppl. 2 2010
37. W.M. Herrmann, W.J. Bohn-Olszewsky, and G. Kuntz Actovegin infusion treatment in patients with primarily degenerative dementia of the Alzheimer type and multi-infarct dementia Z Geriatr 5 1992 46 55
38. S. Kanowski, E. Kinzler, E. Lehmann, A. Schweizer, and G. Kuntz Confirmed clinical efficacy of actovegin in elderly patients with organic brain syndrome Pharmacopsychiatry 28 4 Jul. 1995 125 133
39. D. Parade, G. Biro, and H. Ketti Studies on the insulin-like action of a low molecular-weight blood extract on the glucose metabolism of isolated adipose tissue of the rat in vitro Arzneimittel-Forschung/Drug Res 18 1968 1019 1021
40. K.H. Jaeger, K. Leybold, H. Mittenzwei, H. Staudinger, and L. von Waldstatten Promotion of cell respiration by a blood extract Arzneimittelforschung 15 7 Jul. 1965 750 754
41. H. de Groot, M. Brecht, and F. Machicao Evidence for a factor protective against hypoxic liver parenchymal cell injury in a protein-free blood extract Res Commun Chem Pathol Pharmacol 68 1 Apr. 1990 125 128
42. H. Mochida, T. Kikuchi, H. Tanaka, A. Ikeda, Y. Fujii, and T. Sasamura Influence of actovegin containing infusion solutions on wound healing and function of the intestinal tract in rats Pharmacol Ther 17 1989 789 797
43. S. Tamou, and K.R. Trott Modification of late radiation damage in the rectum of rats by deproteinized calf blood serum (ActoHorm) and pentoxifylline (PTX) Strahlenther Onkol 170 7 Jul. 1994 415 420
44. M.W. Elmlinger, M. Kriebel, and D. Ziegler Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro Neuromolecular Med 13 4 Dec. 2011 266 274
45. N.A. Shamalov, L.V. Stakhovskaia, I.M. Shetova, N.M. Efremova, and K.V. Anisimov Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke Zh Nevrol Psikhiatr Im S S Korsakova 110 9 Pt 2 2010 13 17